← All organizations

CytoDyn, Inc.

For profitWebsite ↗

Also known as: CytoDyn, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Feb 28, 2025

Timeline

2000s

Jun 1, 2002
CytoDyn, Inc.— Founded

Drugs by trial phase (4 distinct, 24 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (24)

NCT04313075Lead sponsorN/A—
NCT06699836Lead sponsorPhase 2Feb 28, 2025
NCT05730673Lead sponsorPhase 2Sep 20, 2022
NCT04901689CollaboratorPhase 3Oct 23, 2021
NCT04901676CollaboratorPhase 3Sep 9, 2021
NCT04678830Lead sponsorPhase 2Jan 21, 2021
NCT04521114Lead sponsorPhase 2Oct 1, 2020
NCT04504942Lead sponsorPhase 2May 1, 2020
NCT04347239Lead sponsorPhase 2Apr 15, 2020
NCT04343651Lead sponsorPhase 2Apr 1, 2020
NCT03838367Lead sponsorPhase 1/Phase 2Apr 22, 2019
NCT03902522Lead sponsorPhase 2/Phase 3Jun 25, 2018
NCT05271370Lead sponsorPhase 2/Phase 3Aug 29, 2017
NCT02737306Lead sponsorPhase 2Nov 1, 2016
NCT02990858Lead sponsorPhase 2/Phase 3Oct 1, 2016

Details

Founded: Vancouver, WA, US Jun 1, 2002
Last known activity: Feb 28, 2025